How do you pay?

How to pay the least

Cash price

$2,320+ for 30 tablets

Pharmacies pay about this for Tivicay; you’d pay more.

  1. Ask your pharmacy for Tivicay’s cash price, and one or two other pharmacies too.
  2. Tivicay’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify ViiV Healthcare Patient Assistance Program (PAP). Patients whose income exceeds program eligibility maximum will be provided the opportunity to demonstrate that their eligible medical expenses bring them within the income eligibility criteria (please contact program for details). Or call 1-844-588-3288.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameTivicay
Authorized genericdolutegravir
Regular genericdolutegravir
What you’d pay
At least$2,320for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Tivicay?
The original
–
–

Brand nameThe maker’s card

ViiVConnect Copay Program

Savings card from ViiV Healthcare

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

The card takes up to $5,000 a year off your co-pay.

Sign up on viivconnect.com 

Or call 1-844-588-3288.

In the maker’s words

“Eligible Patients may pay as little as $0 on each prescription fill…”

From the maker’s offer on viivconnect.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Tivicay itself, from the same company, sold without the brand name, and usually for less. For now Tivicay is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

TIVICAY and TIVICAY PD are an HIV-1 integrase strand transfer inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults (treatment-naïve or -experienced) and in pediatric patients (treatment-naïve or -experienced but INSTI- naïve) weighing at least 2 kg.

TIVICAY is indicated in combination with rilpivirine as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure or known substitutions associated with resistance to either antiretroviral agent.

Source: the FDA label for Tivicay (ViiV Healthcare Company), August 25, 2026. Full label on DailyMed 

Good to know